| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $513.2M | $402.7M | $389.3M |
| YoY Revenue Growth % | +27.4% | +3.5% | — |
| Gross Profit | $221.0M | $167.2M | — |
| Gross Margin % | 43.1% | 41.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $146.2M | $95.6M | $90.7M |
| Operating Margin % | 28.5% | 23.7% | 23.3% |
| Net Income (GAAP) | $115.6M | $74.2M | $77.7M |
| EBITDA (Normalized) | $149.5M | $101.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $190.7M | $108.0M | $103.8M |
| Capital Expenditures (CapEx) | $4.1M | $7.7M | — |
| Free Cash Flow (FCF) | $186.6M | $100.2M | $103.8M |
| FCF Margin % | 36.4% | 24.9% | 26.7% |
| Return on Invested Capital (ROIC %) | 18.1% | 11.9% | — |
| Cash & Short-Term Equivalents | $129.6M | $88.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $766.3M | $724.3M | — |